As expected, insulin resistance treatment diminished the insulin-stimulated GLUT4-myc signal, denoting reduced GLUT4 translocation/PM integration, relative to control cells (Figure 3G, bar 4 vs. bar 2). The gene discussed is SLC2A4; the disease is Insulin resistance.